Gambro Healthcare has been operating as an independent company since July 2007, 100% focused on renal services. As a consequence, Gambro Healthcare is now changing name to Diaverum. Dag Andersson, formerly Molnlycke Healthcare, has been appointed CEO and assumes responsibility January 7, 2008.
Gambro Healthcare has been one of the world’s leading providers of renal services for over 15 years and has a patient base of over 13,000 patients worldwide. In July 2007 Gambro Holding sold Gambro Healthcare to the private equity firm Bridgepoint. “As a stand alone company with 100 % focus on renal services and clinic operations, we at Diaverum can work even harder to provide our patients and other stakeholders with the absolute best renal services,” says Dag Andersson, new CEO. “I feel very excited to become part of a leading healthcare company focusing solely on service. I am looking forward to, together with my team around the world, growing this business over the next coming years”.
The new name
Diaverum is a name with two key facets. The first part, ‘dia’, represents Diaverum’s core activity, dialysis, and signals that Diaverum focuses exclusively on renal services. The second part ‘verum’ means truth in Latin. Hence this new name is symbolic of the honesty, transparency and reliability that the company will continue to be known for.
No changes for the patients
Though the name on the clinic doors and the name badges on the doctors and nurses will say Diaverum, for the patients everything else will stay the same. The treatment will proceed as usual, and the nurses, doctors and other clinic personnel will be the ones that the patients know and trust already.
Going even further
The number of patients with kidney failure is increasing globally. Diaverum will respond to the need for further dialysis capacity by expanding our operations around the globe.
“As renal service specialists we will continue to build on our global knowledge and our dedication to continuous improvement. Our goal is to provide the best renal services available – assuring superior medical outcomes, considerate personalized patient services and support, as well as streamlined and professional clinic operations,” says Dr. Jorgen Hegbrant, Senior Medical Director & VP Medical Operations.
The name change to Diaverum will be implemented throughout Diaverum clinics over the coming year.
Diaverum is one of the world’s leading providers of renal care services, and offers a full range of end-stage renal disease treatment and patient care. The business is the second largest corporate provider of dialysis care services in Europe with 170 clinics in 14 countries serving more than 13,000 patients and with ancillary businesses in South America and Australia.
For further information please visit our website: www.diaverum.com
This information was brought to you by Cision http://newsroom.cision.com
Comments